BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 25772768)

  • 21. Serum anti-mullerian hormone concentrations are not altered by acute administration of follicle stimulating hormone in polycystic ovary syndrome and normal women.
    Wachs DS; Coffler MS; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2007 May; 92(5):1871-4. PubMed ID: 17299061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 17 beta-Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals.
    Pache TD; Hop WC; de Jong FH; Leerentveld RA; van Geldorp H; Van de Kamp TM; Gooren LJ; Fauser BC
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):565-71. PubMed ID: 1424181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
    Lunsford AJ; Whelan K; McCormick K; McLaren JF
    Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.
    Weintraub A; Margalioth EJ; Chetrit AB; Gal M; Goldberg D; Alerhand S; Eldar-Geva T
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():163-7. PubMed ID: 24630573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of testosterone and antimüllerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy.
    Sjaarda LA; Mumford SL; Kuhr DL; Holland TL; Silver RM; Plowden TC; Perkins NJ; Schisterman EF
    Fertil Steril; 2018 Mar; 109(3):540-548.e1. PubMed ID: 29428315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating antimüllerian hormone and steroid hormone levels remain high in pregnant women with polycystic ovary syndrome at term.
    Piltonen TT; Giacobini P; Edvinsson Å; Hustad S; Lager S; Morin-Papunen L; Tapanainen JS; Sundström-Poromaa I; Arffman RK
    Fertil Steril; 2019 Mar; 111(3):588-596.e1. PubMed ID: 30630591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.
    Pierre A; Peigné M; Grynberg M; Arouche N; Taieb J; Hesters L; Gonzalès J; Picard JY; Dewailly D; Fanchin R; Catteau-Jonard S; di Clemente N
    Hum Reprod; 2013 Mar; 28(3):762-9. PubMed ID: 23321213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.
    Borrás A; Manau MD; Fabregues F; Casals G; Saco A; Halperin I; Mora M; Goday A; Barral Y; Carmona F
    Reprod Biomed Online; 2021 Aug; 43(2):289-297. PubMed ID: 34244072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancer.
    Eldar-Geva T; Liberty G; Chertin B; Fridmans A; Farkas A; Margalioth EJ; Spitz IM
    Eur J Endocrinol; 2010 Jan; 162(1):177-81. PubMed ID: 19820037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.
    Desforges-Bullet V; Gallo C; Lefebvre C; Pigny P; Dewailly D; Catteau-Jonard S
    Fertil Steril; 2010 Jun; 94(1):198-204. PubMed ID: 19361798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause.
    Cui L; Qin Y; Gao X; Lu J; Geng L; Ding L; Qu Z; Zhang X; Chen ZJ
    Fertil Steril; 2016 Feb; 105(2):481-5.e1. PubMed ID: 26549157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials.
    Nelson SM; Klein BM; Arce JC
    Fertil Steril; 2015 Apr; 103(4):923-930.e1. PubMed ID: 25624196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.
    Catteau-Jonard S; Pigny P; Reyss AC; Decanter C; Poncelet E; Dewailly D
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4138-43. PubMed ID: 17698904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
    Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
    Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
    van Rooij IA; Broekmans FJ; Scheffer GJ; Looman CW; Habbema JD; de Jong FH; Fauser BJ; Themmen AP; te Velde ER
    Fertil Steril; 2005 Apr; 83(4):979-87. PubMed ID: 15820810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.